Literature DB >> 3306603

Adenosine deaminase mRNA expression is regulated posttranscriptionally during differentiation of HL-60 cells.

T M Berkvens, F Schoute, H van Ormondt, P M Khan, A J van der Eb.   

Abstract

The expression of the enzyme adenosine deaminase (ADA) decreases in the course of the differentiation of the human promyelocytic leukemic cell line HL-60, dependent on the pathway chosen. Differentiation to monocytes as induced by the phorbol ester TPA leads to a 50% reduction of enzyme activity. Induction to myeloid cells as induced by DMSO has a slower and less extensive (75% remaining activity) effect. The reduction in ADA enzymatic activity is preceded by a 5-10 fold reduction in ADA-specific mRNA which is also more rapid during TPA-induced differentiation. In contrast, c-myc mRNA expression is both in TPA- and DMSO-induced differentiation reduced to less then 5% of its initial level within 4h. Nuclear run-on analysis revealed that the reduction of c-myc-mRNA expression during both TPA- and DMSO-induced differentiation could be ascribed to the abolition of transcription of the third exon, whereas no change in the transcription of the first exon could be observed. No change could be detected in the rate of transcription of either the 5' and 3' parts of the ADA gene during TPA- and DMSO-induced differentiation, indicating that the expression of the ADA gene in HL-60 is controlled at a posttranscriptional level.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3306603      PMCID: PMC306124          DOI: 10.1093/nar/15.16.6575

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  33 in total

1.  Human adenosine deaminase. Purification and subunit structure.

Authors:  P E Daddona; W N Kelley
Journal:  J Biol Chem       Date:  1977-01-10       Impact factor: 5.157

Review 2.  The role of adenosine and 2'-deoxyadenosine in mammalian cells.

Authors:  I H Fox; W N Kelley
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

3.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

Authors:  S J Collins; R C Gallo; R E Gallagher
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

4.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity.

Authors:  E R Giblett; J E Anderson; F Cohen; B Pollara; H J Meuwissen
Journal:  Lancet       Date:  1972-11-18       Impact factor: 79.321

5.  Hereditary hemolytic anemia with increased red cell adenosine deaminase (45- to 70-fold) and decreased adenosine triphosphate.

Authors:  W N Valentine; D E Paglia; A P Tartaglia; F Gilsanz
Journal:  Science       Date:  1977-02-25       Impact factor: 47.728

Review 6.  Adenosine deaminase deficiency and severe combined immunodeficiency disease.

Authors:  L F Thompson; J E Seegmiller
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1980

7.  Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester.

Authors:  G Rovera; D Santoli; C Damsky
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

8.  Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.

Authors:  S J Collins; F W Ruscetti; R E Gallagher; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

9.  Basic defect in the expression of adenosine deaminase in ADA- SCID disease investigated through the cells of an obligate heterozygote.

Authors:  E Herbschleb-Voogt; P L Pearson; J M Vossen; P Meera Khan
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

10.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06
View more
  3 in total

1.  Activity of the adenosine deaminase promoter in transgenic mice.

Authors:  D Valerio; H van der Putten; F M Botteri; P M Hoogerbrugge
Journal:  Nucleic Acids Res       Date:  1988-11-11       Impact factor: 16.971

2.  Adenosine deaminase gene expression is regulated posttranscriptionally in the nucleus.

Authors:  T M Berkvens; F Schoute; H van Ormondt; P Meera Khan; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

3.  Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion.

Authors:  Huabo Wang; Lokendra Sharma; Jie Lu; Paul Finch; Steven Fletcher; Edward V Prochownik
Journal:  Oncotarget       Date:  2015-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.